cablivi

Generic: caplacizumab

Labeler: genzyme corporation
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name cablivi
Generic Name caplacizumab
Labeler genzyme corporation
Dosage Form KIT
Manufacturer
Genzyme Corporation

Identifiers & Regulatory

Product NDC 58468-0225
Product ID 58468-0225_fe7be0ce-ffee-4283-91ee-4a16e7ea2080
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761112
Listing Expiration 2027-12-31
Marketing Start 2019-02-06

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 584680225
Hyphenated Format 58468-0225

Supplemental Identifiers

RxCUI
2110616 2110618

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cablivi (source: ndc)
Generic Name caplacizumab (source: ndc)
Application Number BLA761112 (source: ndc)

Resolved Composition

Strengths
  • 11 mg
  • 1 ml
source: label
Packaging
  • 1 KIT in 1 CARTON (58468-0225-1) * 1 mL in 1 VIAL, GLASS (58468-0227-1) * 1 mL in 1 SYRINGE, GLASS (58468-0229-1)
source: ndc

Packages (1)

58468-0225-1 1 KIT in 1 CARTON (58468-0225-1) * 1 mL in 1 VIAL, GLASS (58468-0227-1) * 1 mL in 1 SYRINGE, GLASS (58468-0229-1)

Ingredients (0)

No ingredient records.

Linked Drug Pages (1)

Cablivi ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "fe7be0ce-ffee-4283-91ee-4a16e7ea2080", "openfda": {"rxcui": ["2110616", "2110618"], "spl_set_id": ["2348f06e-8004-4040-832e-e9e86a39f905"], "manufacturer_name": ["Genzyme Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 CARTON (58468-0225-1)  *  1 mL in 1 VIAL, GLASS (58468-0227-1)  *  1 mL in 1 SYRINGE, GLASS (58468-0229-1)", "package_ndc": "58468-0225-1", "marketing_start_date": "20190206"}], "brand_name": "Cablivi", "product_id": "58468-0225_fe7be0ce-ffee-4283-91ee-4a16e7ea2080", "dosage_form": "KIT", "product_ndc": "58468-0225", "generic_name": "caplacizumab", "labeler_name": "Genzyme Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cablivi", "application_number": "BLA761112", "marketing_category": "BLA", "marketing_start_date": "20190206", "listing_expiration_date": "20271231"}